1. 首页
  2. 产品目录
  3. 医药中间体

4-(4-(4-(4-羟苯基)-1-哌啶基)苯基)-2-[(1S，2S)-1-乙基-2-(苄氧基)丙基]-2，4-二氢-3H-1，2，4-三唑-3-酮,99%

1-((2S，3S)-2-(Benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1，2，4-triazol-5(4H)-one （订货以CAS编码或英文名称为准）

厂家直销
创赛科技提供的所有产品仅用于科研等非医疗用途，非药品不可食用，不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料，可至下方“质量控制”中下载
编号：PA84758
分子式：C30H35N5O3
CAS号：184177-83-1
分子量：513.63
申请试用
货号 品牌 规格 纯度/含量 标准价 优惠价 库存货期 数量 购买
PA84758-1g PERFEMIKER 1g
99%
 ¥443.00 登录后可见
PA84758-5g PERFEMIKER 5g
99%
 ¥1447.00 登录后可见
PA84758-25g PERFEMIKER 25g
99%
 ¥4158.00 登录后可见
中文名称： 2-[(1S,2S)-1-乙基-2-苄氧基丙基]-2,4-二氢-4-[4-[4-(4-羟基苯基)-1-哌嗪基]苯基]-3H-1,2,4-三氮唑-3-酮
中文别名： 2-[(1S,2S)-1-乙基-2-苄氧基丙基]-2,4-二氢-4-[4-[4-(4-羟基苯基)-1-哌嗪基]苯基]-3H-1,2,4-三氮唑-3-酮;2-((1S,2S)-1-乙基-2-苄氧基丙基)-2,4-二氢-4-(4-(4-(4-羟基苯基)-1-哌嗪基)苯基)-3H-1,2,4-三氮唑-3-酮;2-(2,4-二氟苯基)-1-(1H-1,2,4-噻唑-1-基)-3-(4H-1,2,4-三唑-4-基)-2-丙醇;2,4-二氢-4-[[4-(4-羟基苯基)-1-哌嗪基]苯基]-2-(1-甲基丙基)-3H-1,2,4-三氮唑-3-酮;2-[(1S,2S)-1-乙基-2-苄氧基丙基]-2,4-二氢-4-[4-[4-(4-羟基苯基)-1-哌嗪基]苯基]-3H-1,2;4-(4-(4-(4-羟苯基)-1-哌啶基)苯基)-2-[(1S,2S)-1-乙基-2-(苄氧基)丙基]-2,4-二氢-3H-1,2,4-三唑-3-酮;泊沙侧链3;泊沙康唑;泊沙康唑侧链;泊沙康唑中间体O;甲基磷酸乙酯;泊沙康唑中间体10;1-((2S,3S)-2-(苄氧基)戊-3-基)-4-(4-(4-(4-羟基苯基)哌嗪-1-基)苯基)-1H-1,2,4-三氮唑-5(4H)-酮;2-[(1S,2S)-1-乙基-2-苄氧基丙基]-2,4-二氢-4-[4-[4-(4-羟基苯基)-1;泊沙康唑-2;泊沙侧链;泊沙康唑中间体3;泊沙康唑中间体B;泊沙康唑中间体0;泊沙康唑中间体POB
英文名称： 1-((2S，3S)-2-(Benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1，2，4-triazol-5(4H)-one
英文别名： 1-((2S,3S)-2-(Benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one;2-[(1S,2S)-1-ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- 3H-1,2,4-Triazol-3-one,;1-((2S,3S)-2-(Benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)-piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one;2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazo...;2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one;2-[(1S,2S)-1-Ethyl-2-benzyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one;3H-1,2,4-Triazol-3-one, 2-[1-ethyl-2-(phenylmethoxy)propyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-, [S-(R*,R*)]- (9CI);Posaconazole inter-2 3H-1,2,4-Triazol-3-one,2-[(1S,2S)-1-ethyl-2-(phenylmethoxy)propyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-;Posaconazole side chain;Posaconazole int2;Posaconazole Intermediate2;Posazonazole intermediate POB;2-[(1S,2S)-1-Ethyl-2-benzyloxypropyl]-2,4-dihydro-4-[4-[4-(4-;1-((2S,3S)-2-(Benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)-piperazin-1-yl)phenyl)-1H-1,2,4;1-((2S,3S)-2-(Benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)-piperazin-1-yl)phenyl)-1H-1,2,4-tr;2-[(1S,2S)-2-benzyloxy-1-ethyl-propyl]-4-[4-[4-(4-hydroxyphenyl)piperazin-1-yl]phenyl]-1,2,4-triazol-3-one;4-[4-[4-(4-hydroxyphenyl)piperazin-1-yl]phenyl]-2-[(2S,3S)-2-phenylmethoxypentan-3-yl]-1,2,4-triazol-3-one;J-507563;2-((2S,3R)-2-(Benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-2H-1,2,4-triazol-3(4H)-one;1-((2S,3S)-2-(benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl) piperazin-1-yl)phenyl)-1H-1,2,4-triazol-5(4H)-one;BCP08707;QLRPRKJUMRQTOV-IADCTJSHSA-N;1-[(2S,3S)-2-(benzyloxy)pentan-3-yl]-4-{4-[4-(4-hydroxyphenyl)piperazin-1-yl]phenyl}-4,5-dihydro-1H-1,2,4-triazol-5-one;DS-16617;184177-83-1;F16787;AKOS015901158;2-((2S,3S)-2-(benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-2,4-dihydro-3H-1,2,4-triazol-3-one;1-((2s,3s)-2-(benzyloxy)pentan-3-yl) -4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl) phenyl)-1h-1,2,4-triazol-5(4h)-one;2-[(1S,2S)-1-ETHYL-2-(PHENYLMETHOXY)PROPYL]-2,4-DIHYDRO-4-[4-[4-(4-HYDROXYPHENYL)-1-PIPERAZINYL]PHENYL]-3H-1,2,4-TRIAZOL-3-ONE;AH978V32DS;A812840;2-[(1S,2S)-1-Ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]-3H-1,2,4-triazol-3-one;MFCD18374617;2-[(1S,2S)-1-ethyl-2-bezyloxypropyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phenyl]- 3H-1,2,4-Triazol-3-one;CS-M2661;2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]-2,4-dihydro-4-[4-[4-(4-hydroxyphenyl)-1-piperazinyl]phen;3H-1,2,4-TRIAZOL-3-ONE, 2-((1S,2S)-1-ETHYL-2-(PHENYLMETHOXY)PROPYL)-2,4-DIHYDRO-4-(4-(4-(4-HYDROXYPHENYL)-1-PIPERAZINYL)PHENYL...
CAS号： 184177-83-1
分子式： C30H35N5O3
分子量： 513.63
详细描述 博飞美科的4-(4-(4-(4-羟苯基)-1-哌啶基)苯基)-2-[(1S，2S)-1-乙基-2-(苄氧基)丙基]-2，4-二氢-3H-1，2，4-三唑-3-酮,99%为医药中间体,产品稳定,定制速度快,极大地方便了广大科研客户的使用需求。产品包装为1g。查询关键词:医药中间体，184177-83-1，4-(4-(4-(4-羟苯基)-1-哌啶基)苯基)-2-[(1S，2S)-1-乙基-2-(苄氧基)丙基]-2，4-二氢-3H-1，2，4-三唑-3-酮,99%，1-((2S，3S)-2-(Benzyloxy)pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl)piperazin-1-yl)phenyl)-1H-1，2，4-triazol-5(4H)-one，博飞美科，Perfemiker，上海，厂家直销。
搜索质检报告(COA)
相关产品